Recent Updates
Recently added Catalysts
HSTM Positive Sentiment

HealthStream Completes $40 Million Private Placement of Its Common Stock

Tuesday, September 15, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: HealthStream, Inc. has completed a private placement transaction, raising approximately $40 million by issuing 1.5 million shares of its common stock to WJRJJ Ventures, LLC. The shares were sold at a price of $29.50 each. This funding is expected to bolster HealthStream's clinical workforce solutions and overall growth.

Market Sentiment Analysis

POSITIVE FACTORS

  • HealthStream successfully raised $40 million through a private placement.
  • The transaction involved the issuance of 1.5 million shares to a reputable investor.
  • The funding will likely support HealthStream's growth and development initiatives.

Full Press Release Details

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (Nasdaq: HSTM) (the “Company”), a leading healthcare technology platform company for clinical workforce solutions, today announced the completion of a private placement transaction through which WJRJJ Ventures, LLC (“WJRJJ”) acquired a total of 1.5 million shares of the Company’s common stock. In this transaction, the Company issued 1,355,932 shares of common stock to WJRJJ for approximately $40 million in cash at a purchase price of $29.50

Frequently Asked Questions

What was the amount raised by HealthStream?

HealthStream raised approximately $40 million through a private placement.

Who acquired the shares in the private placement?

WJRJJ Ventures, LLC acquired a total of 1.5 million shares of HealthStream's common stock.

At what price were the shares sold?

The shares were sold at a purchase price of $29.50 each.

What will the funding support for HealthStream?

The funding is expected to support HealthStream's growth and development initiatives.

ShareAdd on Google
Tags: HSTM Viatris Investor Conferences Healthcare HealthStream private placement WJRJJ Ventures common stock
Last updated: Sep 15, 2026

Biotech snapshot

Cash runway
$67M liquidity · $0M/mo burn
Low dilution risk